AN2 Therapeutics (ANTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov13

AN2 Therapeutics released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -0.8774

04:00

AN2 Therapeutics released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3089 (forecast USD -0.22)

04:00

Aug13

AN2 Therapeutics released FY2025 Semi-Annual earnings on August 12, 2025 (EST), with actual revenue of USD 0 and EPS of USD -0.5682

03:00

AN2 Therapeutics released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.2141 (forecast USD -0.335)

03:00

Jun30

AN2 Therapeutics Completes Observational Study on Acute Merrony Hypochondroplasia

11:01

Jun20

AN2 Therapeutics Signs Share Exchange Agreement with Coastlands Capital

11:01

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -9.353 M, EPS -0.3089

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.462 M, EPS -0.2141

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -10.65 M, EPS -0.3543

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More